ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
WuXi STA, the drug production division of WuXi AppTec, has agreed to acquire Bristol Myers Squibb’s plant in Couvet, Switzerland. The site produces drug tablets and capsules and will be the Chinese firm’s first plant in Europe. WuXi operates a facility in San Diego that it bought from Ambrx. The deal with BMS is the latest in which a service firm acquires a plant from a drug company.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter